2013-12-12 18:16:38 - New Pharmaceuticals research report from GlobalData is now available from Fast Market Research
Parkinson's disease is the second most common chronic progressive neurodegenerative disorder in the elderly after Alzheimer's disease, affecting 1%-2% of individuals ages =65 years worldwide.
Parkinson's disease is associated with motor symptoms involving bradykinesia, rest tremor, rigidity, and postural disturbances, in addition to non-motor symptoms including hyposmia, rapid eye movements, sleep behavior disorder, and depression. Age, genetics, sex, and environmental exposure increase the risk of developing Parkinson's disease. Conditions such as depression and anxiety have been identified as comorbidities in Parkinson's disease.
In 2012, there were 2,179,414 diagnosed cases of Parkinson's disease in the 8MM. By 2022, GlobalData epidemiologists forecast there will be 2,893,575 diagnosed cases of Parkinson's disease in the 8MM. The US will have the highest number of cases in
2022, followed by Brazil and Japan.
Full Report Details at
- www.fastmr.com/prod/752890_epicast_report_parkinsons_disease_epi ..
The 8MM will be important markets for Parkinson's disease during the next 10 years because these countries have a growing older population. Japan's current and growing elderly population is the strongest contributor and key driver for increases in Parkinson's disease prevalent cases in Japan. With greater advances in accurately detecting and diagnosing Parkinson's disease in addition to creating a globally and nationally recognized Parkinson's disease registry, we can help further improve our epidemiological understanding of this disorder.
* The Parkinson's disease EpiCast Report provides an overview of the risk factors and comorbidities for Parkinson's disease in eight major markets (8MM) (US, France, Germany, Italy, Spain, UK, Japan, and Brazil). It includes a 10-year epidemiological forecast of diagnosed prevalent cases of Parkinson's disease segmented by sex and age (ages 65-85+ years).
* The Parkinson's disease epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
* The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 8MM.
Reasons to Get this Report
* Develop business strategies by understanding the trends shaping and driving the global Parkinson's disease market.
* Quantify patient populations in the global Parkinson's disease market to improve product design, pricing, and launch plans.
* Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Parkinson's disease therapeutics in each of the markets covered.
Report Table of Contents:
1 Table of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2.2 Upcoming Reports
3.1 Disease Background
3.2 Risk Factors and Comorbidities
3.2.1 The risk of developing Parkinson's disease progressively increases with age
3.2.2 The risk for Parkinson's disease is increased with Parkinson's disease-causing mutations
3.2.3 Men are 1.5 times more likely to develop Parkinson's disease than women, though the difference may be the result of varying exposures to environmental factors
3.2.4 Chemicals, along with exposure to other environmental factors, increase the risk of developing Parkinson's disease
3.2.5 38% of Parkinson's disease cases experienced depression and/or anxiety compared with only 8% of controls
3.3 Global Trends
3.4 Forecast Methodology
3.4.1 Sources Used
3.4.2 Sources Not Used
3.4.3 Forecast Assumptions and Methods
3.5 Epidemiological Forecast of Parkinson's Disease (2012-2022)
3.5.1 Prevalent Cases of Parkinson's Disease
3.5.2 Age-Specific Prevalent Cases of Parkinson's Disease
3.5.3 Sex-Specific Prevalent Cases of Parkinson's Disease
3.5.4 Age-Standardized Prevalence of Parkinson's Disease
3.6.1 Epidemiological Forecast Insight
3.6.2 Limitations of the Analysis
3.6.3 Strengths of the Analysis
4.2 About the Authors
4.2.3 Global Director of Epidemiology and Health Policy
4.2.4 Global Head of Healthcare
4.3 About GlobalData
4.4 About EpiCast
List of Tables
1.1 List of Tables
Table 1: Risk Factors and Comorbidities for Parkinson's Disease
Table 2: Sources of Diagnosed Prevalence Data Used in the Epidemiology Forecast
Table 3: 8MM, Diagnosed Prevalent Cases of Parkinson's Disease, Ages ≥65 Years, Both Sexes, N, Select Years, 2012-2022
Table 4: 8MM, Diagnosed Prevalent Cases of Parkinson's Disease, by Age, N (Row %), 2012
Table 5: 8MM, Diagnosed Prevalent Cases of Parkinson's Disease, by Sex, N (Row %), 2012
List of Figures
1.2 List of Figures
Figure 1: 8MM, Age-Adjusted Mortality Rate of Parkinson's Disease, Both Sexes, N, 2011
Figure 2: 8MM, Diagnosed Prevalent Cases of Parkinson's Disease, Ages ≥65 Years, Both Sexes, N, Select Years, 2012-2022
Figure 3: 8MM, Diagnosed Prevalent Cases of Parkinson's Disease, by Age, N, 2012
Figure 4: 8MM, Diagnosed Prevalent Cases of Parkinson's Disease, by Sex, N, 2012
Figure 5: 8MM, Age-Standardized Prevalence (%) of Parkinson's Disease, 2012
GlobalData is a leading provider of global business intelligence including market, competitor, product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team. View more research from GlobalData at www.fastmr.com/catalog/publishers.aspx?pubid=1015
About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.
For more information about these or related research reports, please visit our website at www.fastmr.com
or call us at 1.800.844.8156.